Avuzid T 1000mg/125mg Injection
Marketer
Avunu Life Sciences
Salt Composition
Ceftazidime (1000mg) + Tazobactum (125mg)
Overview Avuzid T 1000mg/125mg Injection
Azithromycin/Tigecycline 1000mg/125mg Injection is a dual-action antibiotic. Its use is indicated for diverse bacterial infections, inhibiting microbial proliferation and infection spread. Administration must be under a physician's direct guidance; strict adherence to the prescribed dosage schedule is crucial, completing the entire course regardless of symptom improvement. Premature cessation may compromise efficacy. Potential side effects include gastrointestinal upset (nausea, vomiting, diarrhea, dyspepsia). Severe or worsening side effects demand immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) necessitate prompt emergency care. Full disclosure of current medications, including over-the-counter drugs, is essential before commencing treatment. Pregnant or lactating individuals require physician consultation prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not affecting driving ability, sedation or dizziness necessitates abstaining from driving. Adequate rest, proper nutrition, and sufficient hydration are recommended for optimal recovery. Monitoring may involve periodic laboratory assessments to gauge therapeutic response.
Primary Ingredients of Avuzid T 1000mg/125mg Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Avuzid T 1000mg/125mg Injection
Infections caused by bacteria
Major Benefits of Avuzid T 1000mg/125mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Avuzid T 1000mg/125mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Avuzid T 1000mg/125mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Avuzid T 1000mg/125mg Injection works:
Avuzid T Injection (1000mg/125mg) combines ceftazidime, a bacterial cell wall synthesis inhibitor, with tazobactam, a beta-lactamase inhibitor. Ceftazidime's antibiotic action disrupts bacterial survival by blocking the formation of their protective outer layer. Tazobactam counters bacterial resistance mechanisms, thereby improving ceftazidime's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Avuzid T 1000mg/125mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Avuzid T (1000mg/125mg) is usually deemed safe for pregnant individuals. Preclinical trials using animals revealed minimal or no negative consequences for fetal development; nevertheless, research involving human subjects is scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Avuzid T (1000mg/125mg) presents minimal risk during lactation. Research in humans indicates negligible transfer to breast milk, posing no discernible harm to infants.
DrivingUNSAFE
The administration of Avuzid T 1000mg/125mg Injection can potentially reduce vigilance, impair visual acuity, and induce drowsiness or dizziness. Operation of a vehicle should be avoided if such effects manifest.
KidneyCAUTION
Careful administration of Avuzid T 1000mg/125mg Injection is advised for individuals with impaired kidney function. Dosage modification for Avuzid T 1000mg/125mg Injection might be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with significant hepatic impairment should use Avuzid T 1000mg/125mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Avuzid T 1000mg/125mg Injection :
Omitting a scheduled dose of Avuzid T 1000mg/125mg Injection necessitates contacting your physician.
Facts to Know About Avuzid T 1000mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently